ArticleCardio-oncology (London, England)2025

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study.

Jan Walter Dhillon Shanmuganathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.